Comparison

Mirdametinib European Partner

Item no. TMO-T6189-200mg
Manufacturer TargetMol
CASRN 391210-10-9
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,995
Citations 1. Barrett SD, et al. Bioorg Med Chem Lett, 2008, 18(24), 6501-6504.
Smiles OC[C@@H](O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias PD325901,PD0325901
Shipping Condition Cool pack
Available
Manufacturer - Targets
MEK|||Apoptosis|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
482.19
Description
Mirdametinib (PD325901) is an MEK inhibitor (IC50=0.33 nM) with selective, non-ATP-competitive, and oral activity. Mirdametinib exhibits antitumor activity by inhibiting p-ERK1/2 expression and inducing apoptosis.
Pathways
Autophagy|||MAPK|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close